The AbioCor totally implantable replacement heart

Area of Science:

• Biomedical Engineering
• Cardiovascular Surgery
• Medical Devices

Background:

• End-stage heart failure presents significant challenges for patients ineligible for transplantation.
• The development of total artificial heart systems aims to provide a viable alternative.
• The AbioCor represents a novel, fully implantable electric heart system.

Purpose of the Study:

• To assess the safety and efficacy of the first-generation AbioCor artificial heart.
• To evaluate the device in adult patients with end-stage biventricular heart failure and limited life expectancy.

Main Methods:

• A clinical feasibility study approved by the Food and Drug Administration.
• Implantation of the AbioCor device in adult patients not suitable for heart transplantation.
• Monitoring of survival rates, quality of life, and device performance.

Main Results:

• Four out of seven patients achieved the study's success criteria (60-day survival with improved quality of life).
• Two patients were discharged from the hospital, and four could engage in outpatient activities.
• No device malfunctions or device-related infections were reported during the initial phase.

Conclusions:

• The AbioCor artificial heart demonstrates initial safety and potential efficacy in select end-stage heart failure patients.
• Further enrollment and ongoing trials are necessary to fully establish the long-term outcomes.
• This technology offers a potential solution for patients with limited therapeutic options.